Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence ... - Seeking Alpha
March 30, 2007| Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence ... Seeking Alpha, NY - If HE3286 passes its safety tests, Hollis-Eden expects to put the drug in tests for type 2 diabetes and rheumatoid arthritis. In pre-clinical studies, ... |